Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Study acronym: ELEGANCE
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 66 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 83 → 86 locations
  2. Study sites: 82 to 83
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 4 words
  3. Study sites: 80 to 82v64
  4. Study sites: 79 to 80v63
  5. Re-verified, no change to tracked fieldsv62
Show 45 earlier versionsHide 45 earlier versions
  1. Site details revised at 1 of 79 sitesv61
  2. Site details revised at 2 of 79 sitesv60
  3. Site details revised at 1 of 79 sitesv59
  4. Site details revised at 2 of 79 sitesv58
  5. Site details revised at 4 of 79 sitesv57
  6. 2 versions Re-verified since Nov 13, 2025, no change to tracked fieldsv55-v56
  7. Site details revised at 2 of 79 sitesv54
  8. Site details revised at 1 of 79 sitesv53
  9. 2 versions Re-verified since Jul 16, 2025, no change to tracked fieldsv51-v52
  10. Site details revised at 3 of 79 sitesv50
  11. Study sites: 78 to 79v49
  12. Site contacts updated at 46 of 78 sitesv48
  13. Study sites: 77 to 78v47
  14. Site contacts updated at 45 of 77 sitesv46
  15. Re-verified, no change to tracked fieldsv45
  16. Study sites: 76 to 77v44
  17. Site contacts updated at 43 of 76 sitesv43
  18. Site details revised at 1 of 76 sitesv42
  19. Study sites revised (76)v41
  20. Re-verified, no change to tracked fieldsv40
  21. Site details revised at 6 of 76 sitesv39
  22. Study sites: 75 to 76v38
  23. Site details revised at 1 of 75 sitesv37
  24. Re-verified, no change to tracked fieldsv36
  25. Study sites: 74 to 75v35
  26. Study sites: 73 to 74v34
  27. Re-verified, no change to tracked fieldsv33
  28. Study sites revised (73)v32
  29. Study sites: 72 to 73v31
  30. Site details revised at 2 of 72 sitesv30
  31. Study sites: 71 to 72v29
  32. Study sites: 70 to 71v28
  33. Site details revised at 1 of 70 sitesv27
  34. Study sites: 68 to 70v26
  35. Study sites: 67 to 68v25
  36. Study sites: 64 to 67v24
  37. Site details revised at 1 of 64 sitesv23
  38. 2 versions Re-verified since Jan 17, 2023, no change to tracked fieldsv21-v22
  39. Study sites: 63 to 64v20
  40. Re-verified, no change to tracked fieldsv19
  41. Site details revised at 3 of 63 sitesv18
  42. Study sites: 62 to 63v17
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
Trial Details
NCT Number NCT04674969
Lead Sponsor Boston Scientific Corporation
Conditions
(from sponsor)		 Peripheral Vascular Diseases
Related terms Peripheral Vascular Diseases
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov